Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patient focused benefit risk assessment�� why when how should epidemiologists get
… unmet need A Gap Analysis Target Product Profile (TPP) Assessment A Strengths, Weaknesses, Opportunities & Threats … strategy, for the best positioning of your product, you should begin in Phase 2 of clinical development. Tasks to support the strategy should include the following activities. …
… Real-World Evidence You Need, When You Need It Visit our Real-World Evidence Services Page … create reports for regulatory and HTA purposes as well as publications, interactive tools, and models to help you … different based on the needs of the specific products and patient populations. Our researchers are happy to meet with …
… Given your product’s treatment features, do you know how much your patient’s value it? Willingness-to-pay (WTP) can be estimated … valuation. WTP studies provide a monetary measure of benefit and can answer questions like what’s it worth to a …
… Applications, Pediatric Investigation Plans, Environmental Risk Assessments), pharmacovigilance, and risk management … of treatment or procedure Populations at particular risk Benefit-risk assessments Because literature reviews often … development programs. Incidence of adverse events among a patient population or those taking a certain drug. Review of …
… 2016 RTI Health Solutions Joins Collaborative to Include Patient Risk Preference in Clinical Trials RESEARCH TRIANGLE PARK, NC … that will work with Parkinson’s patients to determine the benefit and risk tradeoffs they are willing to make for a …
… may be considered relevant in determining clinical benefit: Cure, survival, progression-free survival, or … or other factors that are of importance to patients and patient-reported outcomes Changes to productivity, … (evLYG), Healthy Years in Total (HYT), and the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) approach. However, …
… How are United States ICER'S Evidence Ratings Determined? You … that evaluates health technologies in the US. ICER’s value assessment framework is similar to frameworks used by major … by the level of certainty and comparative net health benefit. We conducted a systematic review of evidence reports …
… also be flexible, transparent, and user-friendly, which is why we staff all projects with senior researchers and … and other stochastic process models Simulation (individual patient, discrete-event, etc.) Infectious disease models … analysis Our Approach From design to deliverables, publications , and ongoing support, we develop and validate …
… How Are Companies Responding to Expected Challenges with … manufacturers are preparing to navigate joint clinical assessment (JCA) in several ways. On one hand, companies are … appropriate PICOs is of utmost importance. Manufacturers should be ready to prepare evidence in advance and nimbly …
… Health Technology Assessment (HTA) Utility Measures: Not One-Size-Fits-All HTA … EQ-5D-Y is recommended. A direct measure can be performed when there is no applicable instrument for indirect … measures. • Recommend using an indirect method with patient-level data collected from clinical trials. Health …